Biblioteca Humberto Rosselli Quijano
Información del autor
Autor H. Brent Solvason |
Documentos disponibles escritos por este autor (2)
Refinar búsquedaPredictors of response in anxiety disorders / H. Brent Solvason en Psychiatric Clinics of North America, Año 2003 - Vol. 26 No. 2 (Junio)
Título : Predictors of response in anxiety disorders Tipo de documento: texto impreso Autores: H. Brent Solvason, Autor ; Heidemarie Ernst, Autor ; Walton Roth, Autor Fecha de publicación: 2020 Artículo en la página: pp. 411-433 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos de ansiedad, Pronóstico, Drogas psicotrópicas, Índice de gravedad de la enfermedad. Resumen: Anxiety disorder variables such as duration, severity of illness, and comorbidity with other anxiety or mood disorders appear to identify individuals who are at the greatest risk of treatment nonresponse. Conversely, in accord with clinical experience, shorter periods of illness, less severe illness, being treatment naive, and the absence of comorbidity tend to identify patients who are likely to respond robustly to medication management. Link: ./index.php?lvl=notice_display&id=24814
in Psychiatric Clinics of North America > Año 2003 - Vol. 26 No. 2 (Junio) . - pp. 411-433[artículo] Predictors of response in anxiety disorders [texto impreso] / H. Brent Solvason, Autor ; Heidemarie Ernst, Autor ; Walton Roth, Autor . - 2020 . - pp. 411-433.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2003 - Vol. 26 No. 2 (Junio) . - pp. 411-433
Palabras clave: Trastornos de ansiedad, Pronóstico, Drogas psicotrópicas, Índice de gravedad de la enfermedad. Resumen: Anxiety disorder variables such as duration, severity of illness, and comorbidity with other anxiety or mood disorders appear to identify individuals who are at the greatest risk of treatment nonresponse. Conversely, in accord with clinical experience, shorter periods of illness, less severe illness, being treatment naive, and the absence of comorbidity tend to identify patients who are likely to respond robustly to medication management. Link: ./index.php?lvl=notice_display&id=24814
Título : A prospective trial of bupropion sr augmentation of partial and non-responders to serotonergic antidepressants Tipo de documento: texto impreso Autores: Charles DeBattista, Autor ; H. Brent Solvason, Autor ; Jennifer Poirier, Autor Fecha de publicación: 2023 Artículo en la página: pp. 27-30 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos de segunda generación, Bupropión, Trastorno depresivo, Resistencia al medicamento, Inhibidores selectivos de la recaptación de serotonina. Resumen: Many patients fail to achieve an adequate response to a given antidepressant trial. The best-studied augmentation agents, lithium and thyroid supplementation are less commonly used. Augmenting antidepressants with bupropion has become an increasingly common strategy in the treatment of resistant depression. Several case reports and 2 open label studies suggest efficacy of this strategy. Link: ./index.php?lvl=notice_display&id=31041
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 27-30[artículo] A prospective trial of bupropion sr augmentation of partial and non-responders to serotonergic antidepressants [texto impreso] / Charles DeBattista, Autor ; H. Brent Solvason, Autor ; Jennifer Poirier, Autor . - 2023 . - pp. 27-30.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 27-30
Palabras clave: Antidepresivos de segunda generación, Bupropión, Trastorno depresivo, Resistencia al medicamento, Inhibidores selectivos de la recaptación de serotonina. Resumen: Many patients fail to achieve an adequate response to a given antidepressant trial. The best-studied augmentation agents, lithium and thyroid supplementation are less commonly used. Augmenting antidepressants with bupropion has become an increasingly common strategy in the treatment of resistant depression. Several case reports and 2 open label studies suggest efficacy of this strategy. Link: ./index.php?lvl=notice_display&id=31041
